These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5456917)

  • 1. A unified method for regional anticoagulation of blood.
    Durie MD; Hansebout RR; Peterson EW; Ringer TR
    Am J Surg; 1970 Sep; 120(3):341-5. PubMed ID: 5456917
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heparin-protamine-protocol].
    Nomoto S
    Nihon Geka Hokan; 1997 May; 66(2):49-50. PubMed ID: 9796248
    [No Abstract]   [Full Text] [Related]  

  • 3. Improved survival rates in dogs after extracorporeal circulation by improved control of heparin levels.
    Akkerman JW; Runne WC; Sixma JJ; Zimmerman AN
    J Thorac Cardiovasc Surg; 1974 Jul; 68(1):59-65. PubMed ID: 4834066
    [No Abstract]   [Full Text] [Related]  

  • 4. [Value of the determination of activated coagulation time for decreasing heparin and protamine sulfate doses during operations with artificial circulation].
    Savina ME; Piatnitskaia GK; Kukaeva EA; Charnaia MA; Charnyĭ ISh
    Anesteziol Reanimatol; 1981; (5):52-6. PubMed ID: 7325386
    [No Abstract]   [Full Text] [Related]  

  • 5. Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols.
    Bull BS; Korpman RA; Huse WM; Briggs BD
    J Thorac Cardiovasc Surg; 1975 May; 69(5):674-84. PubMed ID: 1127966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total cardiopulmonary bypass, myocardial contractility, and the administration of protamine sulfate.
    Gourin A; Streisand RL; Stuckey JH
    J Thorac Cardiovasc Surg; 1971 Jan; 61(1):160-6. PubMed ID: 5540459
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel approach to anticoagulation control.
    Kim JS; Vincent C; Teng CL; Wakefield TW; Yang VC
    ASAIO Trans; 1989; 35(3):644-6. PubMed ID: 2597555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin rebound. Studies in patients and volunteers.
    Ellison N; Beatty CP; Blake DR; Wurzel HA; MacVaugh H
    J Thorac Cardiovasc Surg; 1974 May; 67(5):723-9. PubMed ID: 4823307
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
    Evenepoel P; Dejagere T; Verhamme P; Claes K; Kuypers D; Bammens B; Vanrenterghem Y
    Am J Kidney Dis; 2007 May; 49(5):642-9. PubMed ID: 17472846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of pre-arrest heparin administration dose for cardiac arrest model using extracorporeal lung and a heart assist (ECLHA) in dogs.
    Ichinose K; Okamoto T; Tashiro M; Tanimoto H; Terasaki H
    Resuscitation; 2006 May; 69(2):311-8. PubMed ID: 16460866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation with prostaglandins during extracorporeal circulation.
    Kozek-Langenecker SA
    Wien Klin Wochenschr; 1999 Feb; 111(4):129-40. PubMed ID: 10192145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin dosage in extracorporeal circulation and its neutralization.
    Nyman D; Thurnherr N; Duckert F
    Thromb Diath Haemorrh; 1975 Feb; 33(1):102-4. PubMed ID: 1118825
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cardiopulmonary bypass and blood coagulation].
    Kitaguchi K; Furuie H
    Masui; 2001 Dec; 50 Suppl():S115-20. PubMed ID: 11871083
    [No Abstract]   [Full Text] [Related]  

  • 14. [Monitoring of heparin therapy during extracorporeal bypass: what are the remaining questions?].
    Jude B; Lasne D; Mouton C; de Moerloose P; ; ;
    Ann Fr Anesth Reanim; 2004 Jun; 23(6):589-96. PubMed ID: 15234724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety issues in heparin and protamine administration for extracorporeal circulation.
    Jobes DR
    J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):17-20. PubMed ID: 9583571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The benefit of heparin-bound circuits.
    Moulijn AC; Amsel BJ
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):557-8. PubMed ID: 8751535
    [No Abstract]   [Full Text] [Related]  

  • 18. [Present state of heparin therapy].
    Blatrix C; Soulier JP; Vacheron A; Cornu P
    Presse Med (1893); 1969 Mar; 77(15):553-6. PubMed ID: 5796027
    [No Abstract]   [Full Text] [Related]  

  • 19. Extracorporeal circulation: practical considerations for the anesthetist.
    Thomas HL
    AANA J; 1981 Dec; 49(6):565-76. PubMed ID: 7324809
    [No Abstract]   [Full Text] [Related]  

  • 20. Control of hemorrhage following cardiopulmonary bypass.
    Verska JJ
    Ann Thorac Surg; 1972 Jan; 13(1):87-8. PubMed ID: 4257778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.